{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:25:32Z","timestamp":1773469532636,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.anndiagpath.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T12:44:26Z","timestamp":1519217066000},"page":"27-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Aziza E.","family":"Abdelrahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anan","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman A.","family":"Elsebai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashwa","family":"Nawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed M.","family":"Etman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3802\/jgo.2015.26.2.87","article-title":"Oncology FCoG. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication","volume":"26","author":"Prat","year":"2015","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0015","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","article-title":"Latest research and treatment of advanced-stage epithelial ovarian cancer","volume":"10","author":"Coleman","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0025","first-page":"422","article-title":"Evolution of surgery in advanced epithelial ovarian cancer in a dedicated gynaecologic oncology unit-seven year audit from a tertiary care centre in a developing country","volume":"8","author":"Rajanbabu","year":"2014","journal-title":"E Cancer Med Sci"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/cncr.25649","article-title":"Trichostatin a restores Apaf-1 function in chemoresistant ovarian cancer cells","volume":"117","author":"Tan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0045","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1023\/B:APPT.0000045786.98031.1d","article-title":"Apoptosome dysfunction in human cancer","volume":"9","author":"Hajra","year":"2004","journal-title":"Apoptosis"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0050","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1600-0625.2005.00360.x","article-title":"Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance","volume":"14","author":"Campioni","year":"2005","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2018.02.005_bb0055","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ejca.2007.01.029","article-title":"Loss of APAF-1 expression is associated with tumor progression and adverse prognosis in colorectal cancer","volume":"43","author":"Zlobec","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12967-015-0439-7","article-title":"Aquaporins as diagnostic and therapeutic targets in cancer: how far we are?","volume":"13","author":"Wang","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000012067","article-title":"Prognostic value of p27 (Kip1) and Cyclin D1 expression in esophageal cancer","volume":"57","author":"Itami","year":"1999","journal-title":"Oncologia"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ijc.10151","article-title":"Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients","volume":"98","author":"Umekita","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0075","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3748\/wjg.v11.i14.2117","article-title":"Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis","volume":"11","author":"Li","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2018.02.005_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10549-009-0370-9","article-title":"Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas","volume":"120","author":"Otterbach","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00404-011-1908-8","article-title":"Proliferation inhibition of cisplatin and AQP-5expression in human ovarian cancer cell CAOV3","volume":"285","author":"Yang","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0090","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbamem.2009.03.009","article-title":"Aquaporins are multifunctional water and solute transporters highly divergent in living organisms","volume":"1788","author":"Gomes","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.anndiagpath.2018.02.005_bb0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2005.08.054","article-title":"Expression and localization of AQP-5in the epithelial ovarian tumors","volume":"100","author":"Yang","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2018.02.005_bb0100","first-page":"264","article-title":"Overexpression of \u03b2-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2018.02.005_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0110","series-title":"Lyon: international agency for research on cancer","article-title":"WHO classification of tumors of female reproductive organs","author":"Kurman","year":"2014"},{"issue":"2","key":"10.1016\/j.anndiagpath.2018.02.005_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Gynecological Cancer Intergroup. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/gyno.1999.5373","article-title":"The concurrent expression of p27 (kip1) and Cyclin D1 in epithelial ovarian tumors","volume":"73","author":"Sui","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000369073","article-title":"Expression of Aquaporin-1, Aquaporin-3, and AQP-5Correlates with nodal metastasis in colon cancer","volume":"88","author":"Kang","year":"2015","journal-title":"Oncology"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"TCGA","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0140","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(09)61157-0","article-title":"Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial","volume":"374","author":"Katsumata","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.anndiagpath.2018.02.005_bb0145","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"Baldwin","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2018.02.005_bb0150","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1055\/s-0035-1558079","article-title":"Statement by the kommission ovar of the AGO: the new FIGO and WHO classifications of ovarian, fallopian tube and primary peritoneal cancer","volume":"75","author":"Meinhold-Heerlein","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0155","series-title":"International scholarly research notices","first-page":"953509","article-title":"Recent advancements in prognostic factors of epithelial ovarian carcinoma","volume":"vol. 2014","author":"Ezzati","year":"2014"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0160","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/cncr.20709","article-title":"Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis","volume":"101","author":"Takai","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13277-011-0235-9","article-title":"Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population","volume":"33","author":"Ahmad","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0170","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/sj.bjc.6603482","article-title":"Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethy448 lating agents in bladder and kidney cancer","volume":"95","author":"Christoph","year":"2006","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.anndiagpath.2018.02.005_bb0175","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ygyno.2005.01.044","article-title":"Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia","volume":"97","author":"Leo","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"72","key":"10.1016\/j.anndiagpath.2018.02.005_bb0180","first-page":"26","article-title":"Immunohistochemical study of Aquaporin-1, Cyclooxygenase\u20112 and apoptosis protease-activating Factor-1 expression in breast cancers: preliminary study","volume":"1","author":"D\u00e9nes","year":"2013","journal-title":"ARS Med"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0185","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1158\/1078-0432.CCR-03-0751","article-title":"Cyclin D1, p53, and p21Waf1\/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer","volume":"10","author":"Bali","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0190","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00432-015-2077-0","article-title":"Expression and regulation of Ca361 cyBP\/SIP in chronic lymphocytic leukemia cell balances of 362 cell proliferation with apoptosis","volume":"363","author":"Fu","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"36","key":"10.1016\/j.anndiagpath.2018.02.005_bb0195","doi-asserted-by":"crossref","first-page":"34244","DOI":"10.1074\/jbc.M011778200","article-title":"Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity","volume":"276","author":"Wolf","year":"2001","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.anndiagpath.2018.02.005_bb0200","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1182\/blood-2004-03-0954","article-title":"Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia","volume":"104","author":"Roman-Gomez","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0205","first-page":"924","article-title":"Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance","volume":"62","author":"Liu","year":"2002","journal-title":"Cancer Res"},{"issue":"6817","key":"10.1016\/j.anndiagpath.2018.02.005_bb0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35051606","article-title":"Inactivation of the apoptosis effector Apaf-1 in malignant melanoma","volume":"409","author":"Soengas","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3892\/etm.2011.194","article-title":"Cyclin D1 predicts the prognosis of advanced serous ovarian cancer","volume":"2","author":"Hashimoto","year":"2011","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0220","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1158\/1078-0432.CCR-04-2419","article-title":"Overexpression of Cyclin D1 promotes tumor cell growth and confers resistance to cisplatin mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line","volume":"11","author":"Biliran","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0225","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1158\/1078-0432.CCR-08-1564","article-title":"AOCS Study Group: integrated copy number and expression analysis of chemoresistant ovarian carcinomas","volume":"15","author":"Etemadmoghadam","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0230","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.23964","article-title":"Inhibition of Cyclin D1 expression by Cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity","volume":"124","author":"Zhou","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0235","first-page":"1197","article-title":"Localisation and expression of aquaporin subtypes in epithelial ovarian tumours","volume":"26","author":"Yang","year":"2011","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0240","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2353\/ajpath.2008.071198","article-title":"Role of human aquaporin\u20115 in colorectal carcinogenesis","volume":"173","author":"Kang","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00404-011-1942-6","article-title":"Inhibitory effect of epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression","volume":"285","author":"Yan","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0250","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s13277-013-0712-4","article-title":"Aquaporin-5 promotes the proliferation and migration of human gastric carcinoma cells","volume":"34","author":"Huang","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002594","article-title":"Human Aquaporin-5 plays a role in the progression of chronic myelogenous leukemia (CML)","volume":"3","author":"Chae","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0260","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1038\/sj.onc.1206762","article-title":"Involvement of aquaporins in colorectal carcinogenesis","volume":"22","author":"Moon","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0265","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1007\/s13277-014-2169-5","article-title":"The emerging role of aquaporin-5 (AQP-5) expression in systemic malignancies","volume":"35","author":"Xu","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/206525","article-title":"Prognostic value of combined aquaporin-3 and aquaporin-5 overexpression in hepatocellular carcinoma","volume":"2013","author":"Guo","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0275","first-page":"1149","article-title":"Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays","volume":"26","author":"Mobasheri","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0280","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ctrv.2013.09.013","article-title":"Lymphatic spread, nodal count and the extent of lymphadenectomy in cancer of the colon","volume":"40","author":"Willaert","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.anndiagpath.2018.02.005_bb0285","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1007\/s13277-014-1956-3","article-title":"AQP-5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells","volume":"35","author":"Shi","year":"2014","journal-title":"Tumour Biol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913417303775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913417303775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T16:58:23Z","timestamp":1568134703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913417303775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":57,"alternative-id":["S1092913417303775"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2018.02.005","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}